Ian N. Fleming

3.0k total citations
72 papers, 2.5k citations indexed

About

Ian N. Fleming is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ian N. Fleming has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ian N. Fleming's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Medical Imaging Techniques and Applications (8 papers) and Peptidase Inhibition and Analysis (8 papers). Ian N. Fleming is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Medical Imaging Techniques and Applications (8 papers) and Peptidase Inhibition and Analysis (8 papers). Ian N. Fleming collaborates with scholars based in United Kingdom, United States and Italy. Ian N. Fleming's co-authors include C. Peter Downes, John H. Exton, Stephen A. Watt, John M. Lucocq, Gursant Kular, Alexander Gray, Stephen J. Yeaman, Biza Stenfert Kroese, Matteo Zanda and Fiona J. Gilbert and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Geochimica et Cosmochimica Acta.

In The Last Decade

Ian N. Fleming

69 papers receiving 2.5k citations

Peers

Countries citing papers authored by Ian N. Fleming

Since Specialization

Citations

This map shows the geographic impact of Ian N. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian N. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian N. Fleming more than expected).

Fields of papers citing papers by Ian N. Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian N. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian N. Fleming. The network helps show where Ian N. Fleming may publish in the future.

Co-authorship network of co-authors of Ian N. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Ian N. Fleming. A scholar is included among the top collaborators of Ian N. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian N. Fleming. Ian N. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Near-equilibrium kinetics in the Fe(II)-silicate system and the significance of nanoparticle greenalite in Archaean Iron Formations 2025 ·Geochimica et Cosmochimica Acta ·(unknown), (unknown), Michael Nightingale, Juan Carlos de Obeso, Qin Zhang, Ian N. Fleming, Rosalie Tostevin, Nicholas J. Tosca, Benjamin M. Tutolo	1
2	Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMA 2020 ·Annals of Clinical and Translational Neurology ·(unknown), Sergio Dall’Angelo, J. Martin Collinson, Ian N. Fleming, Simon H. Parson	8
3	A role for spinal cord hypoxia in neurodegeneration 2019 ·Cell Death and Disease ·(unknown), Ian N. Fleming, Simon H. Parson	24
4	Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy: routes to glycogen synthase kinase 3 2016 ·Scientific Reports ·Su Phyu, Chih‐Chung Tseng, Ian N. Fleming, Timothy Smith	15
5	Changes in [18F]Fluoro-2-deoxy-d-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling 2015 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Ian N. Fleming, Su Phyu, Timothy Smith	12
6	Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α 2014 ·Breast Cancer Research and Treatment ·Ian N. Fleming, (unknown), Timothy Smith	15
7	A Localized Tolerance in the Substrate Specificity of the Fluorinase Enzyme enables “Last‐Step” ¹⁸F Fluorination of a RGD Peptide under Ambient Aqueous Conditions 2014 ·Angewandte Chemie International Edition ·Stephen Thompson, Qingzhi Zhang, Mayca Onega, S.A. McMahon, Ian N. Fleming, Sharon Ashworth, James H. Naismith, Jan Passchier, David O’Hagan	45
8	Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas 2014 ·British Journal of Cancer ·Gillian Bain, Elaina Collie–Duguid, Graeme I. Murray, Fiona J. Gilbert, (unknown), Fergus McKiddie, Thomas U. Ahearn, Ian N. Fleming, John Leeds, Perminder Phull, (unknown), Shayanthan Nanthakumaran, (unknown), Patrick Tan, A. Welch, (unknown), (unknown), (unknown), (unknown), Russell Petty	53
9	Imaging tumour hypoxia with positron emission tomography 2014 ·British Journal of Cancer ·Ian N. Fleming, Roido Manavaki, Philip J. Blower, Catharine West, Kaye J. Williams, Adrian L. Harris, Juozas Domarkas, Simon Lord, (unknown), Fiona J. Gilbert	241
10	Regional anaesthesia for trauma: an update 2013 ·Continuing Education in Anaesthesia Critical Care & Pain ·Ian N. Fleming, C. Egeler	24
11	Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of αvβ3 integrin receptor 2013 ·Organic & Biomolecular Chemistry ·Sergio Dall’Angelo, Qingzhi Zhang, Ian N. Fleming, Monica Piras, Lutz F. Schweiger, David O’Hagan, Matteo Zanda	29
12	Positron emission tomography radiopharmaceutical studies in humans 2012 ·Nuclear Medicine Communications ·Ian N. Fleming, (unknown), (unknown), Fiona J. Gilbert, Paul M. Matthews, Franklin I. Aigbirhio	4
13	Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials 2012 ·European Radiology ·Eric O. Aboagye, Fiona J. Gilbert, Ian N. Fleming, Ambros J. Beer, Vincent J. Cunningham, Paul Marsden, Dimitris Visvikis, Antony D. Gee, (unknown), Laura Kenny, Gary Cook, Paul E. Kinahan, (unknown), (unknown)	12
14	Building PET research collaborations 2011 ·Nuclear Medicine Communications ·Ian N. Fleming, Fiona J. Gilbert, Philip J. Blower	1
15	Maternal myasthenia gravis complicated by fetal arthrogryposis multiplex congenita 2010 ·International Journal of Obstetric Anesthesia ·(unknown), Ian N. Fleming, N. Parry, (unknown)	10
16	Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C δ1 2002 ·Biochemical Journal ·Stephen A. Watt, Gursant Kular, Ian N. Fleming, C. Peter Downes, John M. Lucocq	302
17	Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components 2000 ·Biochemical Journal ·Ian N. Fleming, Alexander Gray, C. Peter Downes	102
18	Lysophosphatidic Acid Induces Threonine Phosphorylation of Tiam1 in Swiss 3T3 Fibroblasts via Activation of Protein Kinase C 1997 ·Journal of Biological Chemistry ·Ian N. Fleming, (unknown), John G. Collard, John H. Exton	77
19	Differential Translocation of Rho Family GTPases by Lysophosphatidic Acid, Endothelin-1, and Platelet-derived Growth Factor 1996 ·Journal of Biological Chemistry ·Ian N. Fleming, (unknown), John H. Exton	143
20	Goal planning with elderly people : how to make plans to meet an individual's needs : a manual of instruction 1986 ·Manchester University Press eBooks ·Christine Barrowclough, Ian N. Fleming	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact